Evidence map›Paper›PMID 38714540›Full record

ArticleActa neuropathologica2024

Impaired GABAergic regulation and developmental immaturity in interneurons derived from the medial ganglionic eminence in the tuberous sclerosis complex.

Mirte Scheper, Frederik N F Sørensen, Gabriele Ruffolo, Alessandro Gaeta, Lilian J Lissner, Jasper J Anink, Irina Korshunova, Floor E Jansen, Kate Riney, Wim van Hecke and 6 more

Abstract read
In one paragraph

Article in Acta neuropathologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Focal postnatal deletion ofFrontiers in molecular neuroscience · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mirte ScheperDepartment of (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. m.scheper@amsterdamumc.nl.ORCID 0000-0002-0676-4701
Frederik N F SørensenBiotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
Gabriele RuffoloDepartment of Physiology and Pharmacology, University of Rome Sapienza, 00185, Rome, Italy.
Alessandro GaetaDepartment of Physiology and Pharmacology, University of Rome Sapienza, 00185, Rome, Italy.
Lilian J LissnerDepartment of Physiology and Pharmacology, University of Rome Sapienza, 00185, Rome, Italy.
Jasper J AninkDepartment of (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Irina KorshunovaBiotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
Floor E JansenDepartment of Child Neurology, Brain Center University Medical Center, Member of ERN EpiCare, 3584 BA, Utrecht, The Netherlands.
Kate RineyFaculty of Medicine, The University of Queensland, St Lucia, QLD, 4067, Australia.
Wim van HeckeDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Angelika MühlebnerDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Konstantin KhodosevichBiotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
Dirk SchubertDepartment of Cognitive Neurosciences, Radboudumc, Donders Institute for Brain Cognition and Behaviour, 6525 HR, Nijmegen, The Netherlands.
Eleonora PalmaDepartment of Physiology and Pharmacology, University of Rome Sapienza, 00185, Rome, Italy.
James D Mills *Department of (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Eleonora Aronica *Department of (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.

Funding

ZonMw 95105004
6 · The paper itself

Abstract

GABAergic interneurons play a critical role in maintaining neural circuit balance, excitation-inhibition regulation, and cognitive function modulation. In tuberous sclerosis complex (TSC), GABAergic neuron dysfunction contributes to disrupted network activity and associated neurological symptoms, assumingly in a cell type-specific manner. This GABAergic centric study focuses on identifying specific interneuron subpopulations within TSC, emphasizing the unique characteristics of medial ganglionic eminence (MGE)- and caudal ganglionic eminence (CGE)-derived interneurons. Using single-nuclei RNA sequencing in TSC patient material, we identify somatostatin-expressing (SST+) interneurons as a unique and immature subpopulation in TSC. The disrupted maturation of SST+ interneurons may undergo an incomplete switch from excitatory to inhibitory GABAergic signaling during development, resulting in reduced inhibitory properties. Notably, this study reveals markers of immaturity specifically in SST+ interneurons, including an abnormal NKCC1/KCC2 ratio, indicating an imbalance in chloride homeostasis crucial for the postsynaptic consequences of GABAergic signaling as well as the downregulation of GABA

Indexed as

GABAergic NeuronsInterneuronsTuberous SclerosisAnimalsGanglionic EminenceHumansMedian EminenceReceptors, GABA-ASomatostatinReceptors, GABA-ASomatostatinGABAergic interneuronsGanglionic eminenceImmaturitysnRNA-seqSomatostatin

Identifiers

PMID38714540
PMCPMC11076412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.